The Neuromuscular Disease Network for Canada

funder-logos_nmd4c

COVID-19 care recommendations for people using home-based ventilation

Le français suit

 

As COVID-19 continues to affect our daily lives, it is critical that we try to limit the spread of the virus as much as possible. This is especially applicable for patients who use non-invasive positive-pressure ventilation (NIPPV), mechanical airway clearance devices, or are supported by home ventilation for other chronic respiratory failure syndromes.

Chronic respiratory failure conditions include:

  • Amyotrophic lateral sclerosis (ALS)
  • Chronic obstructive pulmonary disease (COPD)
  • Complicated pneumonia
  • Cystic fibrosis
  • Duchenne muscular dystrophy
  • Myotonic dystrophy
  • Severe obesity hypoventilation syndrome
  • Spinal cord injuries
  • Spinal muscular atrophy
  • Thoracic cage disorders

NIPPV devices can increase the risk of infectious particles being dispersed into the environment, which can then infect the people around you. This risk is especially concerning with poor fitting mask interfaces, high leak, and open ventilation systems with tracheostomy.

To help limit the spread of these particles, the CHEST Foundation has provided recommendations and guidelines to help keep you and your loved ones stay as healthy as possible, which can be downloaded HERE.

***

 

 

 

 

Comme la COVID-19 continue d’affecter notre vie quotidienne, il est essentiel que nous essayions de limiter la propagation du virus autant que possible. Cela s’applique en particulier aux patients qui utilisent la ventilation non invasive (VNI) à pression positive, les dispositifs mécaniques de dégagement des voies respiratoires, ou qui sont soutenus par une ventilation à domicile pour d’autres syndromes d’insuffisance respiratoire chronique.

Les affections liées à l’insuffisance respiratoire chronique comprennent :

  • La sclérose latérale amyotrophique (SLA)
  • Maladie pulmonaire obstructive chronique (MPOC)
  • Pneumonie compliquée
  • Fibrose kystique
  • La dystrophie musculaire de Duchenne
  • La dystrophie myotonique
  • Syndrome d’hypoventilation de l’obésité sévère
  • Lésions de la moelle épinière
  • Atrophie musculaire de la colonne vertébrale
  • Troubles de la cage thoracique

Les VNI à pression positive peuvent augmenter le risque de dispersion de particules infectieuses dans l’environnement, qui peuvent ensuite infecter les personnes autour de vous. Ce risque est particulièrement préoccupant pour les interfaces de masque mal ajustées, les fuites importantes et les systèmes de ventilation ouverts avec trachéotomie.

Pour aider à limiter la propagation de ces particules, CHEST Foundation ont fourni des recommandations et des lignes directrices pour aider vous et vos proches à rester en bonne santé autant que possible, qui vous pouvez télécharger ICI.

 

 

 

virus

Read next...

writing-1149962_1920

Letter to provincial governments regarding SMA therapy outcome measures

A group of Canadian neuromuscular disease specialists who care for adults with SMA have written a letter to the provincial governments outlining their concerns and recommending an alternative timeline for outcome measurements in patients receiving the therapies. See our summary of the letter here.

jodi-warman

NMD4C steering committee member awarded Tier 2 Clinical Research Chair

We are very proud to congratulate our steering committee member, Dr. Jodi Warman Chardon, for her new appointment at the University of Ottawa! Dr. Warman Chardon is now the Tier 2 Clinical Research Chair in Diagnosis and Discovery Pipeline for Patients with Genetic Neuromuscular Disease.

Annotation 2020-07-03 092543

A national spinal muscular atrophy registry for real world evidence

Recently, the Canadian Neuromuscular Disease Registry (CNDR) undertook an iterative multi-stakeholder process to expand its spinal muscular atrophy (SMA) dataset to capture items relevant to patient outcomes in the use of the new therapies such as nusinursen (Spinraza).

email-3249062_1280

July 2020 newsletter

Topics include a new national biobank/biorepository virtual catalogue, NMD4C and Muscular Dystrophy Canada (MDC)’s webinar series, exciting new grants from Jesse’s Journey, MDC’s COVID-19 response, new research from NMD4C participants, and a member spotlight on steering committee member Dr. Jodi Warman Chardon.

Webinars-Genetics of Myopathies

Upcoming webinar: The genetics of congenital myopathies in French Canadians

NMD4C and MDC are pleased to invite you to a basic science webinar on July 7, 2020 about the genetics of congenital myopathies in French Canadians.

money-4105043_1920

Exciting research grants awarded by Jesse’s Journey

One of NMD4C’s partners, Jesse’s Journey, recently announced their research grant recipients for 2020. NMD4C is very excited that two of our investigators were awarded funding!